Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Ibrutinib approved by European Commission for newly diagnosed CLL

Ibrutinib approved by European Commission for newly diagnosed CLL

Scientists discover mechanism that turns mutant cells into aggressive cancers

Scientists discover mechanism that turns mutant cells into aggressive cancers

Study finds elevated cancer risk among women with new-onset atrial fibrillation

Study finds elevated cancer risk among women with new-onset atrial fibrillation

Evidence of link between cancer and light therapy inconclusive but warrants consideration

Evidence of link between cancer and light therapy inconclusive but warrants consideration

Taking the brakes of Natural Killer cells to fight cancer

Taking the brakes of Natural Killer cells to fight cancer

Genetic basis of immune evasion via PD-L1 pathway

Genetic basis of immune evasion via PD-L1 pathway

ASCO 2016: PD-1 inhibitor pembrolizumab provides long-term survival benefit for patients with advanced myeloma

ASCO 2016: PD-1 inhibitor pembrolizumab provides long-term survival benefit for patients with advanced myeloma

ASCO 2016: Stem cell transplant remains important for multiple myeloma, even in novel agent era

ASCO 2016: Stem cell transplant remains important for multiple myeloma, even in novel agent era

Researchers reveal how a new class of drugs kills cancer cells

Researchers reveal how a new class of drugs kills cancer cells

Cancer can be combated with reprogrammed macrophage cells

Cancer can be combated with reprogrammed macrophage cells

More from ecancer